Used primarily in the treatment of vertigo associated with Ménière’s disease, this compound helps reduce the frequency and severity of symptoms such as dizziness, tinnitus, and hearing loss. It acts as a histamine H1 receptor agonist and H3 receptor antagonist, improving inner ear circulation by promoting vasodilation in the microvasculature of the labyrinth. This enhanced blood flow helps normalize pressure in the endolymphatic system, contributing to symptom relief. It is also investigated for use in other vestibular disorders and has shown potential in managing certain types of migraines and cognitive conditions due to its effects on cerebral blood flow and neurotransmitter activity.